Hemochromatosis and Iron Storage Disorders

[1]  R. Loomba,et al.  Promising therapies for treatment of nonalcoholic steatohepatitis , 2016, Expert opinion on emerging drugs.

[2]  L. Mørkrid,et al.  Blood removal therapy in hereditary hemochromatosis induces a stress response resulting in improved genome integrity , 2016, Transfusion.

[3]  H. Yin,et al.  Icariin regulates systemic iron metabolism by increasing hepatic hepcidin expression through Stat3 and Smad1/5/8 signaling. , 2016, International journal of molecular medicine.

[4]  H. Yin,et al.  Hepcidin: A Promising Therapeutic Target for Iron Disorders , 2016, Medicine.

[5]  Chunwen Pu,et al.  Molecular pathogenesis of hereditary hemochromatosis. , 2016, Histology and histopathology.

[6]  F. Torti,et al.  Modulation of hepcidin to treat iron deregulation: potential clinical applications , 2016, Expert review of hematology.

[7]  J. Barton,et al.  HFE gene: Structure, function, mutations, and associated iron abnormalities. , 2015, Gene.

[8]  K. Kowdley,et al.  Glyceronephosphate O‐acyltransferase as a hemochromatosis modifier gene: Another iron in the fire? , 2015, Hepatology.

[9]  J. Rayo,et al.  High liver FDG uptake on PET/CT in patient with lymphoma diagnosed with hereditary hemochromatosis. , 2015, Clinical nuclear medicine.

[10]  P. Adams,et al.  Epidemiology and diagnostic testing for hemochromatosis and iron overload , 2015, International journal of laboratory hematology.

[11]  V. Subramaniam,et al.  Hepcidin: regulation of the master iron regulator , 2015, Bioscience reports.

[12]  Toshiko Tanaka,et al.  Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis , 2014, Nature Communications.

[13]  P. Brissot,et al.  Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE). , 2014, Hematology/oncology clinics of North America.

[14]  S. Rivella,et al.  IDENTIFICATION OF ERYTHROFERRONE AS AN ERYTHROID REGULATOR OF IRON METABOLISM , 2014, Nature Genetics.

[15]  Jodie L Babitt,et al.  Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis , 2014, Front. Pharmacol..

[16]  A. Pietrangelo,et al.  Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice , 2014, Gastroenterology.

[17]  P. Brissot,et al.  Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis , 2014, Hepatology.

[18]  W. Aronow,et al.  Cardiac Involvement in Hemochromatosis , 2014, Cardiology in review.

[19]  K. Kowdley,et al.  Diagnosis and treatment of hereditary hemochromatosis: an update , 2013, Expert review of gastroenterology & hepatology.

[20]  F. Laine,et al.  Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production , 2013, Hepatology.

[21]  S. Rivella,et al.  Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice. , 2013, The Journal of clinical investigation.

[22]  G. Keyßer,et al.  Erosive and inflammatory joint changes in hereditary hemochromatosis arthropathy detected by low-field magnetic resonance imaging , 2013, Rheumatology International.

[23]  T. Ganz,et al.  Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. , 2012, Blood.

[24]  G. Ramm,et al.  Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: The role of diabetes mellitus , 2012, Hepatology.

[25]  D. English,et al.  HFE C282Y homozygosity is associated with an increased risk of total hip replacement for osteoarthritis. , 2012, Seminars in arthritis and rheumatism.

[26]  K. Kowdley,et al.  Review article: the iron overload syndromes , 2012, Alimentary pharmacology & therapeutics.

[27]  P. D. de Leeuw,et al.  Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial , 2012, Transfusion.

[28]  J. Olynyk,et al.  Screening for hereditary haemochromatosis. , 2012, Pathology.

[29]  James E. Nelson,et al.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease , 2012, Hepatology.

[30]  Elizabeta Nemeth,et al.  Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. , 2011, The Journal of clinical investigation.

[31]  M. Fleming,et al.  Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. , 2011, Blood.

[32]  B. Bacon,et al.  Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases , 2011, Hepatology.

[33]  James E. Nelson,et al.  The hepcidin circuits act: Balancing iron and inflammation , 2011, Hepatology.

[34]  Jian Wang,et al.  Regulation of cellular iron metabolism , 2011, The Biochemical journal.

[35]  James E. Nelson,et al.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease , 2011, Hepatology.

[36]  S. Vukicevic,et al.  BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. , 2010, Gastroenterology.

[37]  J. Crowe,et al.  Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis , 2010, Hepatology.

[38]  J. Alústiza,et al.  Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond. , 2010, World journal of hepatology.

[39]  M. K. Allen.  Hereditary hemochromatosis: a literature review and case report. , 2010, Physiotherapy Canada. Physiotherapie Canada.

[40]  G. Kontoghiorghes,et al.  Iron Chelation Therapy in Hereditary Hemochromatosis and Thalassemia Intermedia: Regulatory and Non Regulatory Mechanisms of Increased Iron Absorption , 2010, Hemoglobin.

[41]  Michael Boutros,et al.  SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. , 2010, Blood.

[42]  T. Ganz,et al.  The Role of Hepcidin in Iron Metabolism , 2009, Acta Haematologica.

[43]  C. Férec,et al.  A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin‐associated iron overload diseases , 2009, British journal of haematology.

[44]  D. English,et al.  A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis , 2009, British journal of haematology.

[45]  R. Hazin,et al.  Recognizing and treating cutaneous signs of liver disease , 2009, Cleveland Clinic Journal of Medicine.

[46]  L. Powell,et al.  The global burden of iron overload , 2009, Hepatology international.

[47]  Y. T. Lee,et al.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. , 2009, Blood.

[48]  D. English,et al.  HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis‐related morbidity , 2009, Hepatology.

[49]  K. Kowdley,et al.  Differences in Hepatic Phenotype Between Hemochromatosis Patients With HFE C282Y Homozygosity and Other HFE Genotypes , 2009, Journal of clinical gastroenterology.

[50]  M. Rela,et al.  Outcome of liver transplantation in hereditary hemochromatosis , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[51]  M. Roth,et al.  Lack of the bone morphogenetic protein BMP6 induces massive iron overload , 2009, Nature Genetics.

[52]  S. Vukicevic,et al.  BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism , 2009, Nature Genetics.

[53]  Leena Peltonen,et al.  Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. , 2009, American journal of human genetics.

[54]  M. Docquier,et al.  Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring‐sideroblasts , 2009, British journal of haematology.

[55]  D. Swinkels,et al.  Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. , 2008, Blood.

[56]  D. English,et al.  The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. , 2008, Gastroenterology.

[57]  J. Olynyk,et al.  Clinical penetrance of C282Y homozygous HFE hemochromatosis , 2008, Expert review of hematology.

[58]  B. Bacon,et al.  Hereditary hemochromatosis in the post‐HFE era , 2008, Hepatology.

[59]  J. Vránová,et al.  High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic , 2008, The British journal of dermatology.

[60]  D. Reboussin,et al.  Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study , 2008, International journal of laboratory hematology.

[61]  H. Shang,et al.  The Neurological Presentation of Ceruloplasmin Gene Mutations , 2008, European Neurology.

[62]  G. Lippi,et al.  The effect of iron depletion on chronic hepatitis C virus infection , 2008, Hepatology international.

[63]  L. Powell,et al.  Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. , 2008, Blood.

[64]  M. Knuiman,et al.  Noncitrus fruits as novel dietary environmental modifiers of iron stores in people with or without HFE gene mutations. , 2008, Mayo Clinic proceedings.

[65]  D. Gertig,et al.  SNP selection for genes of iron metabolism in a study of genetic modifiers of hemochromatosis , 2008, BMC Medical Genetics.

[66]  F. Carvalho,et al.  Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα , 2008, Blood.

[67]  B. Bacon,et al.  Clinical penetrance of hereditary hemochromatosis. , 2008, The New England journal of medicine.

[68]  D. English,et al.  Iron-overload-related disease in HFE hereditary hemochromatosis. , 2008, The New England journal of medicine.

[69]  Clara Camaschella,et al.  Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. , 2008, Blood.

[70]  M. Hentze,et al.  Hfe acts in hepatocytes to prevent hemochromatosis. , 2008, Cell metabolism.

[71]  R. Fontana,et al.  Prevalence of hepatic iron overload and association with hepatocellular cancer in end‐stage liver disease: results from the National Hemochromatosis Transplant Registry , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[72]  G. Porto,et al.  Iron overload and immunity. , 2007, World journal of gastroenterology.

[73]  S. Goh,et al.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin , 2007, Nature Medicine.

[74]  G. Ioannou,et al.  Survival of liver transplant recipients with hemochromatosis in the United States. , 2007, Gastroenterology.

[75]  M. Wessling-Resnick,et al.  Flatiron mice and ferroportin disease. , 2007, Nutrition reviews.

[76]  L. N. Valenti,et al.  Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study , 2007, The American Journal of Gastroenterology.

[77]  John C Wood,et al.  Magnetic resonance imaging measurement of iron overload , 2007, Current opinion in hematology.

[78]  M. Kaito.  Molecular mechanism of iron metabolism and overload in chronic hepatitis C , 2007, Journal of Gastroenterology.

[79]  Ying Lu,et al.  Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. , 2007, Radiology.

[80]  N. Andrews,et al.  Hereditary Hemochromatosis Protein, HFE, Interaction with Transferrin Receptor 2 Suggests a Molecular Mechanism for Mammalian Iron Sensing* , 2006, Journal of Biological Chemistry.

[81]  J. Gollan,et al.  Alcohol Metabolism-mediated Oxidative Stress Down-regulates Hepcidin Transcription and Leads to Increased Duodenal Iron Transporter Expression* , 2006, Journal of Biological Chemistry.

[82]  S. Almeida,et al.  BMC Medical Genetics2006, 7:16 doi:10.1186/1471-2350-7-16 , 2005 .

[83]  D. Hewett,et al.  Screening for hemochromatosis in asymptomatic subjects with or without a family history. , 2006, Archives of internal medicine.

[84]  D. Purdie,et al.  Steatosis is a cofactor in liver injury in hemochromatosis. , 2005, Gastroenterology.

[85]  V. Gordeuk,et al.  Ferroportin (Q248H) mutations in African families with dietary iron overload , 2005, Journal of gastroenterology and hepatology.

[86]  T. S. St. Pierre,et al.  Measurement and Mapping of Liver Iron Concentrations Using Magnetic Resonance Imaging , 2005, Annals of the New York Academy of Sciences.

[87]  W. Sly,et al.  Pathophysiology of hereditary hemochromatosis. , 2005, Seminars in liver disease.

[88]  G. Ramm,et al.  Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. , 2005, Seminars in liver disease.

[89]  J. O'Neil,et al.  Clinical aspects of hemochromatosis. , 2005, Seminars in liver disease.

[90]  C. Férec,et al.  The molecular genetics of haemochromatosis , 2005, European Journal of Human Genetics.

[91]  Y. Kohgo,et al.  Iron accumulation in alcoholic liver diseases. , 2005, Alcoholism, clinical and experimental research.

[92]  D. Reboussin,et al.  Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. , 2005, Genetic testing.

[93]  D. Greenwood,et al.  Diet and genetic factors associated with iron status in middle-aged women. , 2005, The American journal of clinical nutrition.

[94]  N. Polissar,et al.  Survival after liver transplantation in patients with hepatic iron overload , 2005 .

[95]  V. Viprakasit,et al.  Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. , 2005, Blood.

[96]  N. Polissar,et al.  Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. , 2005, Gastroenterology.

[97]  C. Datz,et al.  TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. , 2005, Cytokine.

[98]  E. Thomson,et al.  Hemochromatosis and iron-overload screening in a racially diverse population. , 2005, The New England journal of medicine.

[99]  M. Kaito,et al.  Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C , 2005, Journal of gastroenterology and hepatology.

[100]  J. McDermott,et al.  Hypogonadism in hereditary hemochromatosis. , 2005, The Journal of clinical endocrinology and metabolism.

[101]  A. Donovan,et al.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. , 2005, Cell metabolism.

[102]  James E. Nelson,et al.  Non-HFE hemochromatosis: Genetics, pathogenesis, and clinical management , 2005, Current Gastroenterology Reports.

[103]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[104]  Jennifer J. Pointon,et al.  Recent advances in understanding haemochromatosis: a transition state , 2004, Journal of Medical Genetics.

[105]  J. Barton,et al.  Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. , 2004, Blood.

[106]  A. Pietrangelo.  Non‐HFE hemochromatosis , 2004, Hepatology.

[107]  R. Kittles,et al.  Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. , 2003, Blood cells, molecules & diseases.

[108]  C. Férec,et al.  Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation. , 2003, American journal of epidemiology.

[109]  E. Beutler.  The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. , 2003, Blood.

[110]  H. El‐Serag,et al.  Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis , 2003, Annals of Internal Medicine.

[111]  M. De Gobbi,et al.  Hemochromatosis due to mutations in transferrin receptor 2. , 2002, Blood cells, molecules & diseases.

[112]  J. Olynyk,et al.  Iron as a cofactor in chronic hepatitis C infection. , 2002, Liver.

[113]  B. Bacon,et al.  Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection. , 2002, Journal of hepatology.

[114]  D. Girelli,et al.  Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. , 2002, Gastroenterology.

[115]  L. Powell.  Diagnosis of hemochromatosis. , 2002, Seminars in gastrointestinal disease.

[116]  J. Olynyk,et al.  A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. , 2002, Gastroenterology.

[117]  D. Purdie,et al.  Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. , 2002, Gastroenterology.

[118]  H. Nakamura,et al.  Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases. , 2001, Liver.

[119]  A. Donovan,et al.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. , 2001, The Journal of clinical investigation.

[120]  W. Burke,et al.  HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. , 2001, American journal of epidemiology.

[121]  L. Grummer-Strawn,et al.  Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. , 2001, JAMA.

[122]  Christina H. Park,et al.  Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver* , 2001, The Journal of Biological Chemistry.

[123]  Bruno Turlin,et al.  A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload* , 2001, The Journal of Biological Chemistry.

[124]  A. Moser,et al.  Impaired membrane traffic in defective ether lipid biosynthesis. , 2001, Human molecular genetics.

[125]  W. Griffiths,et al.  Haemochromatosis: novel gene discovery and the molecular pathophysiology of iron metabolism. , 2000, Human molecular genetics.

[126]  P. Brissot,et al.  EASL International Consensus Conference on Haemochromatosis. , 2000, Journal of hepatology.

[127]  Hiroshi Kawabata,et al.  Transferrin Receptor 2-α Supports Cell Growth Both in Iron-chelated Cultured Cells and in Vivo * , 2000, The Journal of Biological Chemistry.

[128]  H. El‐Serag,et al.  Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness Analysis , 2000, Annals of Internal Medicine.

[129]  P. Bjorkman,et al.  Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor , 2000, Nature.

[130]  J. Olynyk,et al.  A population-based study of the clinical expression of the hemochromatosis gene. , 1999, The New England journal of medicine.

[131]  Dena E. Cohen,et al.  The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. , 1999, Blood.

[132]  K. Do,et al.  Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. , 1999, Journal of hepatology.

[133]  M. Cazzola,et al.  Juvenile hemochromatosis locus maps to chromosome 1q. , 1999, American journal of human genetics.

[134]  J. Crowe,et al.  Hemochromatosis in Ireland and HFE. , 1998, Blood cells, molecules & diseases.

[135]  Y. Deugnier,et al.  Evaluation and interpretation of iron in the liver. , 1998, Seminars in diagnostic pathology.

[136]  J. Gitlin,et al.  Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. , 1998, The American journal of clinical nutrition.

[137]  D. Girelli,et al.  Heterogeneity of hemochromatosis in Italy. , 1998, Gastroenterology.

[138]  W. Sly,et al.  HFE gene knockout produces mouse model of hereditary hemochromatosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[139]  M. Kaplan,et al.  Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. , 1997, Gastroenterology.

[140]  D. George,et al.  the screening, diagnosis and optimal management of haemochromatosis , 1997, Alimentary pharmacology & therapeutics.

[141]  J. Barton,et al.  Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. , 1997, Blood cells, molecules & diseases.

[142]  Y. Kurosawa,et al.  Identification of a mouse homolog for the human hereditary haemochromatosis candidate gene. , 1997, Biochemical and biophysical research communications.

[143]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[144]  M. Mattioli,et al.  Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload. , 1996, Journal of hepatology.

[145]  D. Häussinger,et al.  Long-term survival in patients with hereditary hemochromatosis. , 1996, Gastroenterology.

[146]  P. Adams,et al.  Alcoholism in hereditary hemochromatosis revisited: Prevalence and clinical consequences among homozygous siblings , 1996, Hepatology.

[147]  M. Seshadri,et al.  Endocrine abnormalities in hemodialysis patients with iron overload: reversal with iron depletion. , 1995, Nutrition.

[148]  F. J. Farrell,et al.  Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[149]  G. Brittenham,et al.  Experimental liver cirrhosis induced by alcohol and iron. , 1995, The Journal of clinical investigation.

[150]  H. Morita,et al.  Hereditary ceruloplasmin deficiency with hemosiderosis: A clinicopathological study of a japanese family , 1995, Annals of neurology.

[151]  Y Gandon,et al.  Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. , 1994, Radiology.

[152]  A. Skinningsrud,et al.  Serum ferritin and transferrin saturation in patients with chronic alcoholic and non‐alcoholic liver diseases , 1994, Journal of internal medicine.

[153]  J. Hoofnagle,et al.  Measurements of iron status in patients with chronic hepatitis. , 1992, Gastroenterology.

[154]  P. Adams,et al.  Clinical presentation of hemochromatosis: a changing scene. , 1991, The American journal of medicine.

[155]  P. Walfish,et al.  Hypogonadotropic hypogonadism in idiopathic hemochromatosis: evidence for combined hypothalamic and pituitary involvement , 1990, Journal of endocrinological investigation.

[156]  D. Weatherall,et al.  IRON ABSORPTION AND LOADING IN β-THALASSÆMIA INTERMEDIA , 1979, The Lancet.

[157]  R. Fauchet,et al.  Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. , 1976, Gut.

[158]  E. Frieden,et al.  The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. , 1966, The Journal of biological chemistry.

[159]  K. Kowdley,et al.  A Proton Pump Inhibitor a Day Keeps the Iron Away. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[160]  K. Rácz,et al.  Circulating miRNAs as biomarkers for endocrine disorders , 2015, Journal of Endocrinological Investigation.

[161]  A. Anghel,et al.  Hemochromatosis genotypes and risk of iron overload--a meta-analysis. , 2011, Annals of epidemiology.

[162]  M. Bulsara,et al.  Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. , 2011, Arthritis and rheumatism.

[163]  James E. Nelson,et al.  Relationship between gene expression of duodenal iron transporters and iron stores in hemochromatosis subjects. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[164]  K. Okita,et al.  Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. , 2008, Gastroenterology.

[165]  C. Moysés,et al.  Simultaneous detection of the C282Y, H63D and S65C mutations in the hemochromatosis gene using quenched-FRET real-time PCR. , 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[166]  V. Subramaniam,et al.  Protein and Vesicle Trafficking , Cytoskeleton Defective trafficking and localization of mutated transferrin receptor 2 : implications for type 3 hereditary hemochromatosis , 2008 .

[167]  G. Musci,et al.  Iron overload due to mutations in ferroportin. , 2006, Haematologica.

[168]  R. Go,et al.  HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. , 2005, Blood cells, molecules & diseases.

[169]  Marie-Pierre Dubé,et al.  Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.

[170]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.

[171]  J. Hoofnagle,et al.  Molecular medicine and hemochromatosis: at the crossroads. , 1999, Gastroenterology.

[172]  G. Lescoat,et al.  Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. , 1992, Journal of hepatology.

[173]  T. Mountokalakis,et al.  Acute renal failure in G.-6-P.D. , 1972, Lancet.

[174]  T. Bothwell,et al.  IRON OVERLOAD IN BANTU SUBJECTS; STUDIES ON THE AVAILABILITY OF IRON IN BANTU BEER. , 1964, The American journal of clinical nutrition.